Agency Forms Undergoing Paperwork Reduction Act Review, 6862-6863 [2016-02519]
Download as PDF
<![CDATA[
6862
Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR), Lead Poisoning Prevention
(LPP) Subcommittee; Notice of
Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC, National
Center for Environmental Health/
Agency for Toxic Substances and
Disease Registry (NCEH/ATSDR)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 12:00 p.m.–1:45 p.m.,
EST, February 9, 2016.
Place: This meeting will be held by
teleconference. To participate in the
teleconference, please dial 1–877–315–
6535 Passcode: 383520.
Status: The meeting is open to the
public, limited only by the conference
lines available. The public is welcome
to participate during the public
comment period, which is tentatively
scheduled from 1:30 p.m. to 1:45 p.m.
This Federal Register Notice is being
published less than 15 days before the
meeting because of the urgent nature of
recent events involving the Flint,
Michigan water contamination with
lead. CDC is convening a meeting of the
Lead Subcommittee of the Board of
Scientific Counselors to initiate
discussion of public health measures
and assessments needed in response to
this event.
Purpose: The subcommittee will
propose strategies and options to the
Board of Scientific Counselors (BSC) on
ways to prioritize NCEH/ATSDR’s
activities, improve health outcomes, and
address health disparities as it relates to
lead exposures. The subcommittee will
deliberate on ways to evaluate lead
exposure and how to best conduct
health evaluations through exposure
and epidemiologic studies.
Subcommittee proposals on lead
prevention practices and national lead
poisoning prevention efforts will be
provided to the Board of Scientific
Counselors for deliberation and possible
adoption as formal recommendations to
NCEH/ATSDR.
Matters for Discussion: Agenda items
will include the following: Blood lead
testing and health surveillance strategies
for the residents of Flint, Michigan,
including methodological approaches
for conducting retrospective and
VerDate Sep<11>2014
17:54 Feb 08, 2016
Jkt 238001
prospective assessments of blood lead
levels and associated health outcomes.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Sandra Malcom, Committee
Management Specialist, NCEH/ATSDR,
4770 Buford Highway, Mail Stop F–45,
Chamblee, Georgia 30345; telephone
770/488–0575, Fax: 770/488–3377;
Email: smalcom@cdc.gov.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Gary Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Drug Susceptibility Testing
(OMB Control No. 0920–0600, Expires
5/31/2016)—Extension—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–02574 Filed 2–4–16; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–0600]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Background and Brief Description
As part of the continuing effort to
support domestic public health
objectives for treatment of tuberculosis
(TB), prevention of multi-drug
resistance, and surveillance programs,
CDC is requesting approval for an
extension of three years from the Office
of Management and Budget to continue
information collection from participants
in the Model Performance Evaluation
Program for Mycobacterium
Tuberculosis Susceptibility Testing.
Extension of this information collection
will not require changes in the scope of
the study, methodology, information
collection instruments, or burden on the
respondents.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program
for Mycobacterium Tuberculosis Drug
Susceptibility Testing is used to monitor
and evaluate performance and practices
among national laboratories performing
M. tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
Extension of this information
collection provides CDC with an
E:\FR\FM\09FEN1.SGM
09FEN1
6863
Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices
evaluation program to assess the ability
of the laboratories to test for drug
resistant M. tuberculosis strains.
Laboratories also have a self-assessment
tool to aid in optimizing their skills in
susceptibility testing. The information
obtained from the laboratories on
susceptibility practices and procedures
is used to establish variables related to
good performance, assessing training
needs, and aid with the development of
practice standards.
Participants in this program include
domestic clinical and public health
laboratories. Data collection from
laboratory participants occurs twice per
year. The data collected in this program
will include the susceptibility test
results of primary and secondary drugs,
drug concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) samples.
The PE samples are sent to participants
twice a year. Participants also report
demographic data such as laboratory
type and the number of tests performed
annually.
There is no cost to respondents to
participate other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Domestic Laboratory .......................................
Participant Biosafety Compliance Letter of
Agreement.
MPEP Mycobacterium tuberculosis Results
Worksheet.
Online Survey Instrument ..............................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–02519 Filed 2–8–16; 8:45 am]
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–02480 Filed 2–8–16; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Medicare & Medicaid
Services
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC): Notice of Charter
Renewal
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[CMS Computer Match No. 2016–12; HHS
Computer Match No. 1604; SSA Computer
Match No. 1097–1899]
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Committee to the Director,
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS), has been
renewed for a 2-year period extending
through February 1, 2018.
Contact Person For More Information:
Carmen Villar, M.S.W., Designated
Federal Officer, Advisory Committee to
the Director, CDC, 1600 Clifton Road
NE., Mailstop D14, Atlanta, Georgia
30333, Telephone 404–639–7000.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
AGENCY:
VerDate Sep<11>2014
17:54 Feb 08, 2016
Jkt 238001
Privacy Act of 1974
Department of Health and
Human Services (HHS), Centers for
Medicare & Medicaid Services (CMS).
ACTION: Notice of Computer Matching
Program (CMP).
In accordance with the
requirements of the Privacy Act of 1974,
as amended, this notice announces the
re-establishment of a CMP that CMS
plans to conduct with the Social
Security Administration (SSA).
DATES: Effective Dates: Comments are
invited on all portions of this notice.
Public comments are due 30 days after
publication. The matching program will
become effective no sooner than 40 days
after the report of the matching program
is sent to the Office of Management and
Budget (OMB) and Congress, or 30 days
after publication in the Federal
Register, whichever is later.
ADDRESSES: The public should send
comments to: CMS Privacy Officer,
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
93
2
5/60
93
2
30/60
93
2
15/60
Division of Security, Privacy Policy &
Governance, Information Security &
Privacy Group, Office of Enterprise
Information, CMS, Room N1–24–08,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850. Comments
received will be available for review at
this location, by appointment, during
regular business hours, Monday through
Friday from 9:00 a.m.–3:00 p.m., Eastern
Time zone.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Kane, Acting Director,
Verifications Policy & Operations
Division, Eligibility and Enrollment
Policy and Operations Group, Center for
Consumer Information and Insurance
Oversight, CMS, 7501 Wisconsin
Avenue, Bethesda, MD 20814, Office
Phone: (301) 492–4418, Facsimile: (443)
380–5531, E-Mail:
Elizabeth.Kane@cms.hhs.gov.
The
Computer Matching and Privacy
Protection Act of 1988 (Public Law
(Pub. L.) 100–503), amended the Privacy
Act (5 U.S.C. 552a) by describing the
manner in which computer matching
involving Federal agencies could be
performed and adding certain
protections for individuals applying for
and receiving Federal benefits. Section
7201 of the Omnibus Budget
Reconciliation Act of 1990 (Pub. L. 101–
508) further amended the Privacy Act
regarding protections for such
individuals. The Privacy Act, as
amended, regulates the use of computer
matching by Federal agencies when
records in a system of records (SOR) are
matched with other Federal, state, or
local government records. It requires
Federal agencies involved in computer
matching programs to:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09FEN1.SGM
09FEN1
]]>Agencies
[Federal Register Volume 81, Number 26 (Tuesday, February 9, 2016)]
[Notices]
[Pages 6862-6863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02519]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0600]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
CDC Model Performance Evaluation Program (MPEP) for Mycobacterium
tuberculosis Drug Susceptibility Testing (OMB Control No. 0920-0600,
Expires 5/31/2016)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
As part of the continuing effort to support domestic public health
objectives for treatment of tuberculosis (TB), prevention of multi-drug
resistance, and surveillance programs, CDC is requesting approval for
an extension of three years from the Office of Management and Budget to
continue information collection from participants in the Model
Performance Evaluation Program for Mycobacterium Tuberculosis
Susceptibility Testing. Extension of this information collection will
not require changes in the scope of the study, methodology, information
collection instruments, or burden on the respondents.
While the overall number of cases of TB in the U.S. has decreased,
rates still remain high among foreign-born persons, prisoners, homeless
populations, and individuals infected with HIV in major metropolitan
areas. To reach the goal of eliminating TB, the Model Performance
Evaluation Program for Mycobacterium Tuberculosis Drug Susceptibility
Testing is used to monitor and evaluate performance and practices among
national laboratories performing M. tuberculosis susceptibility
testing. Participation in this program is one way laboratories can
ensure high-quality laboratory testing, resulting in accurate and
reliable testing results.
Extension of this information collection provides CDC with an
[[Page 6863]]
evaluation program to assess the ability of the laboratories to test
for drug resistant M. tuberculosis strains. Laboratories also have a
self-assessment tool to aid in optimizing their skills in
susceptibility testing. The information obtained from the laboratories
on susceptibility practices and procedures is used to establish
variables related to good performance, assessing training needs, and
aid with the development of practice standards.
Participants in this program include domestic clinical and public
health laboratories. Data collection from laboratory participants
occurs twice per year. The data collected in this program will include
the susceptibility test results of primary and secondary drugs, drug
concentrations, and test methods performed by laboratories on a set of
performance evaluation (PE) samples. The PE samples are sent to
participants twice a year. Participants also report demographic data
such as laboratory type and the number of tests performed annually.
There is no cost to respondents to participate other than their
time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Domestic Laboratory................... Participant Biosafety 93 2 5/60
Compliance Letter of
Agreement.
MPEP Mycobacterium 93 2 30/60
tuberculosis Results
Worksheet.
Online Survey Instrument 93 2 15/60
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-02519 Filed 2-8-16; 8:45 am]
BILLING CODE 4163-18-P
